Stay updated on Oral Etrasimod in Crohn's Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Etrasimod in Crohn's Disease Clinical Trial page.

Latest updates to the Oral Etrasimod in Crohn's Disease Clinical Trial page
- CheckyesterdayChange DetectedA new site revision is shown: Revision: v3.5.5 replaces the previous v3.5.4, indicating an updated build of the page’s interface.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedVersion 69 (Revision: v3.5.4) was added, introducing several new sections to the record history such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, Study Design, Study Status, and Study Identification; the latest entry also shows Returned: 2026-05-12 and indicates that the Quality Control Review Has Not Concluded.SummaryDifference0.8%

- Check36 days agoChange DetectedThe history section gains an entry for Revision: v3.5.3, replacing the previous v3.5.2. This reflects a new recorded update to the page.SummaryDifference0.0%

- Check43 days agoChange DetectedThe record’s status was updated to indicate that results have been submitted. Previously, the study showed no results posted.SummaryDifference0.0%

- Check51 days agoChange DetectedFooter revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check79 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the record history.SummaryDifference0.0%

Stay in the know with updates to Oral Etrasimod in Crohn's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Etrasimod in Crohn's Disease Clinical Trial page.